Patient 麻豆传媒高清 Resources
Clinicians using the UCHealth EHR can use dotphrase: .pgxdpydtopatientFluoropyrimidines Tip Sheet
The following information is intended for use by providers who are attempting to prescribe fluoropyrimidines, including fluorouracil (5-FU) and capecitabine to patients with certain DPYD genetic variants.
For immediate questions, send a secure chat message to Groups: Pharmacogenomics Service in UCHealth's EHR.
References:
Top Table:
- Adapted from the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing 2017 Update: Amstutz U et al. Clin Pharmacol Ther 2018; 103(2):210-16, PMID: 29152729, and November 2018 update at: .
Bottom Table:
- EFUDEX Product Label. Rev 10/2021.
- Carac Product Label. Rev 05/2021.
- Dutch Pharmacogenetics Working Group. Fluorouracil cutaan 6192. Revised 05/13/2019.
- Johnson MR et al. Clin Cancer Res 1999; 5(8):2006-11. PMID 10473079
Fluoropyrimidines and DPYD Tip Sheet by Christina L. Aquilante is licensed under a .
Based on a work at /cobiobank/providers/results/pgx/dpyd-tipsheet.
Webpage updated as of: 11/8/24